VANCOUVER, British Columbia, Jan. 22, 2026 (GLOBE NEWSWIRE) -- (TSXV: PTF): Pender Growth Fund Inc. (the “Company” or “PTF”) is pleased to report that long-time holding General Fusion Inc. (“General ...
VANCOUVER, British Columbia, Jan. 22, 2026 (GLOBE NEWSWIRE) — (TSXV: PTF): Pender Growth Fund Inc. (the “Company” or “PTF”) is pleased to report that long-time holding General Fusion Inc. (“General ...
The RET fusion-targeted therapy market is set for strong expansion, driven by growing awareness of the oncogenic role of RET gene fusions and encouraging clinical trial outcomes. With the approval of ...
Budget 2026–27 reinforced the government’s urbanisation push, prioritising infrastructure development in tier-II and tier-III cities. The renewed emphasis on these cities is expected to create an ...
The NSCLC market size has undergone a revolutionary transformation over the last decade, driven by an increase in incident cases, the continuous adoption of approved therapies primarily immune ...
Pender Growth Fund Inc. - GlobeNewswire - Thu Jan 22, 7:39AM CST VANCOUVER, British Columbia, Jan. 22, 2026 (GLOBE NEWSWIRE) -- (TSXV: PTF): Pender Growth Fund Inc. (the “Company” or “PTF”) is pleased ...
Belfast-based Fusion Antibodies has conditionally raised £1.4m to accelerate the commercialisation of its OptiMAL platform after its launch was well received. After launching the platform in December, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results